As part of our series of white papers tracking clinical trials activity around the world, GlobalData, a data and analytics company, captured records of 3,199 clinical trials in Australia across all diseases and phases that had a start date between January 2012 and December 2016.
The company analyzed the number of trials carried out by industry and non-industry sponsors, and determined the top sponsors involved in these clinical trials, as well as the top investigational drugs.
Brooke Wilson, healthcare analyst at GlobalData, commented, “Our research showed that Australian clinical trials had between two and three times as many industry sponsors as non-industry sponsors.”
The relative contribution of industry sponsors increased over the first four-year period from 63% to 72%, before experiencing a slight decline to 69% in 2016. In comparison, the non-industry sponsors declined steadily from 37% to 28% from 2012–2015, with a slight increase of 3% in 2016.